More NewsRead More
Navidea Biopharmaceuticals to Announce First Quarter 2016 Financial Results on May 17, 2016
May 10, 2016
Navidea Updates Clinical Development Plan for Diagnostic Use of Lymphoseek® IV in Rheumatoid Arthritis
April 04, 2016
category Publishing & Media
BRIEF-Navidea reports Q1 loss per share of $0.02
May 17, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here